Geometric accuracy of three-dimensional molecular overlays

被引:18
作者
Chen, Qi [1 ]
Higgs, Richard E. [1 ]
Vieth, Michal [1 ]
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
D O I
10.1021/ci060134h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This study examines the dependence of molecular alignment accuracy on a variety of factors including the choice of molecular template, alignment method, conformational flexibility, and type of protein target. We used eight test systems for which X-ray data on 145 ligand-protein complexes were available. The use of X-ray structures allowed an unambiguous assignment of bioactive overlays for each compound set. The alignment accuracy depended on multiple factors and ranged from 6% for flexible overlays to 73% for X-ray rigid overlays, when the conformation of the template ligand came from X-ray structures. The dependence of the overlay accuracy on the choice of templates and molecules to be aligned was found to be the most significant factor in six and seven of the eight ligand-protein complex data sets, respectively. While finding little preference for the overlay method, we observed that the introduction of molecule flexibility resulted in a decrease of overlay accuracy in 50% of the cases. We derived rules to maximize the accuracy of alignment, leading to a more than 2-fold improvement in accuracy (from 19% to 48%). The rules also allowed the identification of compounds with a low (< 5%) chance to be correctly aligned. Last, the accuracy of the alignment derived without any utilization of X-ray conformers varied from < 1% for the human immunodeficiency virus data set to 53% for the trypsin data set. We found that the accuracy was directly proportional to the product of the overlay accuracy from the templates in their bioactive conformations and the chance of obtaining the correct bioactive conformation of the templates. This study generates a much needed benchmark for the expectations of molecular alignment accuracy and shows appropriate usages and best practices to maximize hypothesis generation success.
引用
收藏
页码:1996 / 2002
页数:7
相关论文
共 32 条
[1]  
*ACC, 2006, QUANTA
[2]  
*ACC INC, 2005, CAT VERS 4 9
[3]  
Agresti A., 1990, Analysis of categorical data
[4]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[5]   Assessing the performance of OMEGA with respect to retrieving bioactive conformations [J].
Boström, J ;
Greenwood, JR ;
Gottfries, J .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2003, 21 (05) :449-462
[6]   Virtual screening and rational drug design method using structure generation system based on 3D-QSAR and docking [J].
Chen, HF ;
Dong, XC ;
Zen, BS ;
Gao, K ;
Yuan, SG ;
Panaye, A ;
Doucet, JP ;
Fan, BT .
SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2003, 14 (04) :251-264
[7]  
Chen Q, 1999, QUANT STRUCT-ACT REL, V18, P124, DOI 10.1002/(SICI)1521-3838(199906)18:2<124::AID-QSAR124>3.3.CO
[8]  
2-Z
[9]  
*DAYL CHEM INF SYS, 2005, I MACS KEYS
[10]   Generation of predictive pharmacophore models for CCR5 antagonists: Study with piperidine- and piperazine-based compounds as a new class of HIV-1 entry inhibitors [J].
Debnath, AK .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (21) :4501-4515